MEDY Weight Loss

MEDY Weight Loss in Lathrop, California operates under the clinical direction of Christel Backert, NP-C, a board-certified nurse practitioner specializing in medical weight loss and metabolic optimization. The clinic serves patients throughout California's Central Valley with both in-person consultations at their Lathrop facility and telehealth appointments for California residents seeking physician-supervised weight management programs. Rather than offering one-size-fits-all diet plans, MEDY Weight Loss constructs individualized protocols that address the underlying metabolic factors contributing to weight gain and difficulty losing fat, including insulin resistance, hormonal imbalances, and age-related metabolic decline.

The clinic integrates peptide therapy into comprehensive weight loss programs, specifically utilizing Sermorelin for growth hormone optimization and NAD+ for cellular metabolism support. Sermorelin, a growth hormone-releasing hormone analog, stimulates the pituitary gland's natural production of human growth hormone, which declines with age and contributes to increased body fat, reduced muscle mass, and slower metabolism. NAD+ (nicotinamide adenine dinucleotide) supplementation addresses cellular energy production at the mitochondrial level, supporting metabolic function, reducing inflammation, and improving the body's ability to convert nutrients into usable energy rather than stored fat. These peptide therapies complement FDA-approved weight loss medications and are prescribed based on individual metabolic assessments, body composition analysis, and specific patient goals.

Christel Backert brings board certification and specialized training in metabolic medicine to her practice at MEDY Weight Loss, conducting thorough evaluations that examine thyroid function, hormone levels, nutritional deficiencies, and metabolic markers before designing treatment protocols. Her approach combines pharmaceutical interventions with peptide therapy, nutritional guidance, and lifestyle modification strategies tailored to each patient's medical history, current medications, and realistic implementation capacity. The clinic's programs include regular monitoring of progress through body composition measurements, laboratory testing, and clinical assessments to adjust treatment protocols as patients progress through different phases of weight loss and metabolic improvement.

Patients beginning treatment at MEDY Weight Loss undergo comprehensive initial consultations that include medical history review, current medication assessment, discussion of previous weight loss attempts, and establishment of specific, measurable goals. The clinic provides structured support throughout treatment, including education on proper peptide administration, nutritional planning that accounts for individual food preferences and lifestyle constraints, exercise recommendations scaled to current fitness levels, and strategies for addressing emotional and behavioral aspects of eating patterns. Follow-up appointments track weight loss progress, evaluate treatment response, address any side effects or concerns, and modify protocols based on how individual patients respond to specific interventions.

MEDY Weight Loss maintains accessibility for California residents through both their Lathrop clinic location and telehealth services, allowing patients across the state to access board-certified medical weight loss care without extensive travel requirements. The clinic's telehealth platform enables video consultations for initial evaluations, follow-up appointments, and ongoing support, with medications and peptides shipped directly to patients following appropriate medical assessment and prescription. This dual-access model serves working professionals, parents with scheduling constraints, and patients in rural areas of California who lack local access to specialized metabolic medicine providers, while maintaining the clinical oversight and safety protocols essential for medical weight loss programs involving prescription medications and peptide therapies.